• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型蒽环类抗生素美诺加罗在小鼠体内的处置情况。

The disposition of the new anthracycline antibiotic, menogarol, in mice.

作者信息

Dodion P, Chang B K, Egorin M J, Olman E A, Engisch K L, Bachur N R

出版信息

Drug Metab Dispos. 1984 May-Jun;12(3):365-70.

PMID:6145565
Abstract

We have investigated the metabolism and disposition, in mice, of 7-con-O-methylnogarol ( menogarol ; 7-OMEN), a new anthracycline antibiotic entering clinical trials. 7-OMEN, dissolved in 0.01 M glucuronic acid, was administered iv to mice (10 mg/kg). At specified times after injection, groups of mice were killed and 7-OMEN and metabolites were assayed in plasma and organs by HPLC. Plasma concentrations of 7-OMEN declined in triexponential fashion. The terminal t1/2 was 10.6 hr; the AUC was 10.13 microM X hr; the apparent Vc was 0.4 liter/m2, and the systemic clearance was 91.2 ml/min/m2. One metabolite, with the same HPLC characteristics as N- demethylmenogarol , was seen in plasma during the first 30 min after injection. 7-OMEN was distributed extensively to all tissues except brain. Initially, pulmonary concentrations of 7-OMEN were 15 times higher than those in any other organ and 30 times higher than those in plasma. Concentrations of 7-OMEN were the most persistent in spleen, kidney, and pancreas, and the least persistent in heart and liver. The AUC for 7-OMEN in organs was the greatest in lungs (605 nmol/g X hr), spleen (522 nmol/g X hr), and pancreas (430 nmol/g X hr), and least in heart (33 nmol/g X hr) and liver (60 nmol/g X hr). Kidneys and skeletal muscles had intermediate AUC values. In liver, two metabolites, one of which had the HPLC characteristics of N- demethylmenogarol , were seen. In other organs, the same metabolites were seen later and in small quantities.

摘要

我们研究了新型蒽环类抗生素7-顺式-O-甲基诺加罗(美诺加罗;7-OMEN)在小鼠体内的代谢和处置情况,该药物已进入临床试验阶段。将溶于0.01 M葡萄糖醛酸的7-OMEN静脉注射给小鼠(10 mg/kg)。注射后在特定时间点,处死小鼠组,通过高效液相色谱法(HPLC)测定血浆和器官中的7-OMEN及其代谢产物。7-OMEN的血浆浓度呈三指数方式下降。终末半衰期为10.6小时;曲线下面积(AUC)为10.13 μM·小时;表观分布容积(Vc)为0.4升/平方米,全身清除率为91.2毫升/分钟/平方米。注射后最初30分钟内在血浆中观察到一种代谢产物,其HPLC特征与N-去甲基美诺加罗相同。7-OMEN广泛分布于除脑以外的所有组织。最初,7-OMEN在肺中的浓度比其他任何器官高15倍,比血浆中高30倍。7-OMEN在脾脏、肾脏和胰腺中的浓度持续时间最长,在心脏和肝脏中持续时间最短。7-OMEN在各器官中的AUC在肺中最大(605 nmol/g·小时)、脾脏(522 nmol/g·小时)和胰腺(430 nmol/g·小时),在心脏中最小(33 nmol/g·小时),在肝脏中为(60 nmol/g·小时)。肾脏和骨骼肌的AUC值居中。在肝脏中观察到两种代谢产物,其中一种具有N-去甲基美诺加罗的HPLC特征。在其他器官中,相同的代谢产物出现较晚且数量较少。

相似文献

1
The disposition of the new anthracycline antibiotic, menogarol, in mice.新型蒽环类抗生素美诺加罗在小鼠体内的处置情况。
Drug Metab Dispos. 1984 May-Jun;12(3):365-70.
2
Metabolism and disposition of menogaril (NSC 269148) in the rabbit.美诺加里尔(NSC 269148)在兔体内的代谢与处置
Cancer Res. 1985 Nov;45(11 Pt 1):5352-7.
3
Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.蒽环类抗生素美诺立尔(7-OMEN,NSC 269148)的人体药代动力学、排泄及代谢及其与临床毒性的相关性。
Cancer Res. 1986 Mar;46(3):1513-20.
4
Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.蒽环类抗肿瘤药物美诺加(menogaril)在小鼠、犬和猴体内的药代动力学及全身生物利用度。
Cancer Res. 1989 Nov 15;49(22):6328-36.
5
Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture.几种诺加霉素类似物和阿霉素对培养的中国仓鼠卵巢细胞、L1210白血病细胞和B16黑色素瘤细胞的细胞杀伤动力学。
Cancer Res. 1981 Jan;41(1):18-24.
6
Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.对携带P388或L1210白血病的小鼠口服蒽环类药物7-氧甲基诺加罗(7-OMEN)的活性。
Cancer Treat Rep. 1980 Apr-May;64(4-5):727-9.
7
The murine metabolism and disposition of marcellomycin.
Drug Metab Dispos. 1984 Mar-Apr;12(2):209-16.
8
Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.蒽环类抗生素美诺加(7-OMEN,NSC 269148)的人体药代动力学、排泄及代谢及其与临床毒性的相关性。
Cancer Res. 1986 Sep;46(9):4874.
9
Quantitation of anthracycline antitumor agent menogarol in plasma using liquid chromatography with fluorescence detection.
Anal Chem. 1984 Aug;56(9):1587-90. doi: 10.1021/ac00273a011.
10
Cellular pharmacology of 7(R)-O-methylnogarol: a new anticancer agent.7(R)-O-甲基诺加罗醇的细胞药理学:一种新型抗癌剂
J Pharmacol Exp Ther. 1979 Aug;210(2):229-36.

引用本文的文献

1
Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.蒽环类抗肿瘤药物。物理化学、分析及稳定性性质综述。
Pharm Weekbl Sci. 1986 Apr 25;8(2):109-33. doi: 10.1007/BF02086146.
2
Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors.实体瘤患者中7-顺式-O-甲基诺加罗醇的药代动力学
Cancer Chemother Pharmacol. 1987;20(1):67-70. doi: 10.1007/BF00252962.
3
Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function.肝功能和肾功能异常患者对全剂量美诺加里尔(NSC 269148)的耐受性。
Invest New Drugs. 1990 Nov;8(4):365-7. doi: 10.1007/BF00198592.